Tafinlar (Dabrafenib) 75mg Capsules | BRAF Inhibitor | Novartis Hong Kong | GLT

This product is Tafinlar, the Novartis originator brand of the BRAF inhibitor dabrafenib, supplied from the Hong Kong, China market in 75 mg capsules. The Hong Kong presentation carries English and Chinese labeling as required by the local Department of Health, and it is the same originator product registered in many other markets for BRAF-mutant cancers.

Generic Information: Tafinlar (Hong Kong, China)

Each hard capsule contains 75 mg of dabrafenib as the active ingredient. The standard dose of 150 mg twice daily is reached by taking two 75 mg capsules per administration. This strength is the workhorse of dabrafenib therapy and the one most clinics keep in regular stock.

What Is Tafinlar (Dabrafenib) Used For?

Tafinlar is indicated for patients whose cancer is driven by a BRAF V600 mutation. That includes advanced or metastatic melanoma, adjuvant treatment of resected high-risk melanoma, and — in combination with the MEK inhibitor trametinib — BRAF V600E-mutated metastatic non-small cell lung cancer and anaplastic thyroid cancer.

How Does Tafinlar Work?

Dabrafenib is a small molecule that selectively binds mutated BRAF kinase. By occupying the enzyme, it interrupts the overactive MAPK signal that BRAF-mutant tumor cells rely on for growth and survival. Pairing dabrafenib with trametinib targets the pathway at two levels, which improves tumor response and delays resistance.

Indications

• Metastatic or unresectable melanoma with BRAF V600E or V600K mutation
• Adjuvant melanoma therapy with trametinib after surgery
• BRAF V600E metastatic NSCLC with trametinib
• BRAF V600E anaplastic thyroid cancer with trametinib

Dosage & Administration

Adults take 150 mg (two 75 mg capsules) twice daily with or without food, roughly every 12 hours. Swallow the capsules whole with water. Your oncologist may reduce the dose or pause treatment if fever or other side effects develop; do not change the dose on your own.

Side Effects

Pyrexia is common and can be serious, so patients are taught to monitor their temperature. Other frequent effects are fatigue, skin rash, nausea, headache, chills and joint pain. Less common but serious risks include new primary skin cancers, bleeding, cardiomyopathy, uveitis and hyperglycemia, which is why dermatologic and laboratory monitoring are routine during treatment.

Storage & Handling

Store capsules at room temperature in the original package, protected from moisture and light, and out of reach of children. Do not use after the expiry date.

Why Choose the GLT?

• Hong Kong-sourced originator — Tafinlar supplied from the Hong Kong, China market with proper labeling.
• Batch traceability — documentation provided for institutional procurement.
• Reliable logistics — worldwide delivery with tracking.

How to Order Tafinlar (Hong Kong) from GLT

1. Contact GLT via WhatsApp +86 15234153837 or email [email protected] with your required quantity.
2. Receive a quotation and delivery schedule.
3. Pay through our secure channel (Hao Yi Lian / 好易联).
4. Shipment is dispatched with documentation and tracking.

A valid prescription may be requested before dispatch. We serve hospitals, pharmacies, importers and individual patients.

FAQ

1. Where is this Tafinlar sourced from?

This Tafinlar is sourced from the Hong Kong, China market and is the authentic Novartis originator product.

2. What strength is supplied?

This listing is for the 75 mg capsule, the strength used to make up the 150 mg twice-daily dose.

3. Do I need a prescription?

Yes, dabrafenib requires a prescription, which may be requested before dispatch.